In a nation still negotiating the boundaries between state authority, medical consensus, and parental rights, the Trump administration has moved to remove Medicaid and CHIP coverage for gender-affirming surgeries and hormone treatments for transgender youth under nineteen — a policy taking effect this October, with hormone coverage phased out by April 2027. The decision, directed through the Centers for Medicare and Medicaid Services, extends a broader pattern of federal restrictions on transgender life that began when the administration took office. Where medicine, law, and identity intersect
Trump administration cuts Medicaid funding for transgender youth care
Transgender youth and families face barriers to medical care and mental health support, with advocates warning of psychological harm from policy restrictions.
Therapy alone, without the option of medical care, can feel like being told to accept something that causes real suffering.
Mark
Why does the administration frame this as protecting children rather than restricting access?
Mimi
They're operating from a premise that these treatments are inherently harmful. But that framing sidesteps what medical organizations actually say—that the treatments, when appropriate, can alleviate distress. The word "barbaric" is doing rhetorical work that the evidence doesn't support.
Mark
What happens to a teenager whose doctor and parents agree treatment is right, but Medicaid won't pay?
Mimi
They either go without, or their family pays out of pocket if they can afford it. That creates a two-tier system where access depends on wealth. For many families, that means no access at all.
Mark
The policy keeps mental health coverage. Isn't that something?
Mimi
It's a partial gesture, but it misses the point. Mental health support is important, but for some young people, the distress comes from the mismatch between their body and identity. Therapy alone, without the option of medical care, can feel like being told to accept something that causes real suffering.
Mark
Why are the courts still involved if the administration has the power to change Medicaid policy?
Mimi
Because there are constitutional questions about whether the government can discriminate against a protected class, and whether the factual claims about harm hold up. The lower court already said the "unsafe and ineffective" claim doesn't match the evidence. That's why this will likely end up in front of judges again.
Mark
What's the practical effect on states that already allow this care?
Mimi
It removes federal funding, which pressures hospitals to stop offering it. Even if a state permits the care, if Medicare and Medicaid won't pay, the economics become difficult. It's a backdoor way to restrict care in states that haven't formally banned it.
The Pulse
- A federal policy shift strips Medicaid and CHIP coverage for gender-affirming surgeries and hormones for minors, leaving families who depend on public insurance with narrowing options and an October deadline.
- The move arrives atop an already compressed landscape — at least 27 states have banned such care outright, and even hospitals in permissive states have quietly pulled back from offering treatments.
- LGBTQ+ legal organizations are mobilizing for court challenges, arguing the policy unconstitutionally inserts the government between parents and their children's medical decisions.
- Major medical bodies including the American Medical Association maintain that gender-affirming care is appropriate and supported by evidence, even as some surgical questions remain contested.
- Mental health coverage for transgender youth will technically continue, but advocates warn that blocking medical pathways while leaving psychological distress unaddressed may itself cause serious harm.
- The policy lands in an already crowded legal docket — courts have both permitted some state restrictions and pushed back against federal characterizations of this care as unsafe, leaving the final terrain deeply uncertain.
In a nation still negotiating the boundaries between state authority, medical consensus, and parental rights, the Trump administration has moved to remove Medicaid and CHIP coverage for gender-affirming surgeries and hormone treatments for transgender youth under nineteen — a policy taking effect this October, with hormone coverage phased out by April 2027. The decision, directed through the Centers for Medicare and Medicaid Services, extends a broader pattern of federal restrictions on transgender life that began when the administration took office. Where medicine, law, and identity intersect, the most vulnerable often bear the weight of unresolved public debate — and for thousands of transgender young people and their families, that weight has grown measurably heavier.
The Trump administration announced this week that Medicaid and the Children's Health Insurance Program will stop covering gender-affirming surgeries and hormone treatments for transgender people under nineteen. The policy takes effect October 13, with hormone coverage phased out through April 2027. Mental health services for transgender youth will remain covered.
President Trump directed Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, to implement the change, describing the treatments in a social media post as causing irreversible harm to young bodies. The administration did not disclose how much federal funding currently supports such care.
The announcement is part of a wider campaign of restrictions that has unfolded since Trump returned to office — including plans to cut Medicaid and Medicare funding to hospitals providing gender-affirming care to minors, bans on transgender athletes competing in categories aligned with their gender identity, and limits on passport gender designations. At least 27 states have already enacted their own bans on such care for minors, and many major hospitals have curtailed services even where no formal prohibition exists. Surgeries for minors are rare; puberty blockers and hormone treatments are far more common.
LGBTQ+ advocates condemned the policy and promised legal action. Josh Rovenger of GLBTQ Legal Advocates and Defenders said the rule erects barriers between parents and their ability to make medical decisions for their children. Kelley Robinson of the Human Rights Campaign called it an effort to terrorize transgender youth and their families — an organization already suing the administration over related coverage restrictions under federal employee health plans.
Major medical organizations, including the American Medical Association, support access to gender-affirming care. The American Society of Plastic Surgeons has noted insufficient evidence that surgical interventions for minors outweigh their risks. Most of the administration's transgender policies face active legal challenges; courts have issued mixed rulings, and the cases continue to move through an uncertain judicial landscape while families navigate an increasingly narrow set of options.
The Trump administration announced this week that Medicaid and the Children's Health Insurance Program will no longer pay for gender-affirming surgeries or hormone treatments for transgender people under 19 years old. The policy takes effect October 13, with a phase-out of hormone coverage extending to April 2027. Mental health services for transgender youth will continue to be covered.
President Trump directed Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, to make the change. In a social media post, Trump characterized the treatments as "barbaric surgeries and practices" that cause "unthinkable and irreversible harm" to young bodies. The administration did not disclose how much federal funding currently supports gender-affirming care for transgender youth.
The policy arrives as part of a broader set of restrictions on transgender people that began when Trump took office last year. The administration has already announced plans to cut off Medicaid and Medicare funding for hospitals that provide gender-affirming care to minors, barred transgender athletes from competing in sports categories aligned with their gender identity, and blocked people from selecting male, female, or X designations on passports. A report released last year urged therapy-only approaches for transgender youth rather than broader medical interventions.
The landscape for transgender youth seeking medical care has already shifted significantly. At least 27 states have enacted bans on gender-affirming care for those under 18. Even in states without formal bans, many major hospitals have stopped offering some treatments. Gender-affirming surgeries for minors are uncommon; puberty blockers and hormone treatments are far more prevalent.
LGBTQ+ advocates and legal organizations have signaled they will challenge the policy in court. Josh Rovenger, legal director of GLBTQ Legal Advocates and Defenders, said the rule erects barriers between parents and their ability to make medical decisions for their children. Kelley Robinson, president of the Human Rights Campaign, called the action an effort to terrorize transgender youth and their families. The Human Rights Campaign is already suing the administration over efforts to bar gender-affirming care coverage under federal employee health plans.
Major medical organizations, including the American Medical Association, support access to gender-affirming care. The American Society of Plastic Surgeons, however, stated earlier this year that it found insufficient evidence that the benefits of chest, genital, and facial surgeries on minors with gender dysphoria outweigh the risks. Gender dysphoria refers to the distress some people experience when their assigned sex and gender identity do not align.
Most of the administration's transgender-related policies have faced legal challenges. The Supreme Court allowed some state-level restrictions to stand, though a lower court ruled against the administration's characterization of gender-affirming treatments as unsafe and ineffective. A legal challenge to the hospital funding policy remains pending. As these cases move through the courts, transgender youth and their families navigate a narrowing set of medical options and an uncertain legal terrain.
Notable Quotes
The rule is putting up barriers between parents and their ability to make the best medical decisions for their children.— Josh Rovenger, legal director of GLBTQ Legal Advocates and Defenders
The Trump administration is terrorizing trans youth and their families with these kinds of actions, and it has to stop.— Kelley Robinson, president of the Human Rights Campaign
Want the full story?
Read the original at CBS News ↗
Politics & Governance